Imugene Limited
IUGNF · OTC
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Market Cap | $112,982 | $435,047 | $559,534 | $1,102,264 |
| - Cash | $21,935 | $93,108 | $153,151 | $99,888 |
| + Debt | $10,651 | $1,547 | $553 | $673 |
| Enterprise Value | $101,698 | $343,486 | $406,937 | $1,003,049 |
| Revenue | $4,397 | $4,970 | $11,778 | $12,970 |
| % Growth | -11.5% | -57.8% | -9.2% | – |
| Gross Profit | $4,397 | $4,970 | $9,574 | $10,563 |
| % Margin | 100% | 100% | 81.3% | 81.4% |
| EBITDA | -$67,423 | -$147,978 | -$47,425 | -$35,296 |
| % Margin | -1,533.5% | -2,977.4% | -402.7% | -272.1% |
| Net Income | -$69,022 | -$149,681 | -$37,915 | -$37,869 |
| % Margin | -1,569.8% | -3,011.7% | -321.9% | -292% |
| EPS Diluted | -0.32 | -0.72 | -0.21 | -0.23 |
| % Growth | 55.6% | -242.9% | 8.7% | – |
| Operating Cash Flow | -$75,569 | -$101,726 | -$29,779 | -$30,669 |
| Capital Expenditures | -$14,459 | -$7,074 | $0 | -$258 |
| Free Cash Flow | -$90,027 | -$108,800 | -$29,779 | -$30,926 |